BRPI0410261A - método de detecção de probnp natural - Google Patents

método de detecção de probnp natural

Info

Publication number
BRPI0410261A
BRPI0410261A BRPI0410261-4A BRPI0410261A BRPI0410261A BR PI0410261 A BRPI0410261 A BR PI0410261A BR PI0410261 A BRPI0410261 A BR PI0410261A BR PI0410261 A BRPI0410261 A BR PI0410261A
Authority
BR
Brazil
Prior art keywords
natural
probnp
detection method
detection
probnp detection
Prior art date
Application number
BRPI0410261-4A
Other languages
English (en)
Inventor
Volker Klemt
Anneliese Borgya
Andreas Gallusser
Michael Grol
Klaus Hallermayer
Christoph Seidel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33427054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0410261(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0410261A publication Critical patent/BRPI0410261A/pt
Publication of BRPI0410261B1 publication Critical patent/BRPI0410261B1/pt
Publication of BRPI0410261B8 publication Critical patent/BRPI0410261B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MéTODO DE DETECçãO DE proBNP NATURAL". A presente invenção refere-se a anticorpos que especificamente se ligam ao proBNP natural, a um método para detecção específica de proBNP natural, um método de correlacionar o nível de proBNP natural ao diagnóstico de colapso cardíaco, um kit para detecção de proBNP natural e a uma linha celular de hibridoma que produz um anticorpo para o proBNP natural.
BRPI0410261A 2003-05-12 2004-05-12 anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3 BRPI0410261B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03010591 2003-05-12
EP03010591.0 2003-05-12
PCT/EP2004/005092 WO2004099253A1 (en) 2003-05-12 2004-05-12 Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46

Publications (3)

Publication Number Publication Date
BRPI0410261A true BRPI0410261A (pt) 2006-05-16
BRPI0410261B1 BRPI0410261B1 (pt) 2020-03-10
BRPI0410261B8 BRPI0410261B8 (pt) 2021-07-27

Family

ID=33427054

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410261A BRPI0410261B8 (pt) 2003-05-12 2004-05-12 anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3

Country Status (15)

Country Link
US (4) US7264939B2 (pt)
EP (4) EP2256132B1 (pt)
JP (4) JP5128125B2 (pt)
KR (2) KR100857752B1 (pt)
CN (3) CN100497393C (pt)
AT (2) ATE517124T1 (pt)
AU (1) AU2004235974B2 (pt)
BR (1) BRPI0410261B8 (pt)
CA (2) CA2522747C (pt)
DK (3) DK2256132T3 (pt)
ES (3) ES2372282T3 (pt)
HU (1) HUE025169T2 (pt)
MX (1) MXPA05011826A (pt)
PL (3) PL1625164T3 (pt)
WO (2) WO2004099252A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
EP2256132B1 (en) * 2003-05-12 2015-04-01 Roche Diagnostics GmbH Method of detecting proBNP with a monoclonal antibody
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
DE10355731A1 (de) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
ATE364177T1 (de) * 2004-07-07 2007-06-15 Hoffmann La Roche Kombinationen von markern zum nachweis von typ 1 und 2 diabetes
AT500800B1 (de) 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
JP2010517023A (ja) 2007-01-25 2010-05-20 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｉｇｆｂｐ−７の使用
KR100836322B1 (ko) * 2007-08-31 2008-06-09 현대자동차주식회사 차량용 흡음재 제작장치 및 방법
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
EP2274622B1 (en) 2008-04-30 2014-10-08 The Governing Council of the University of Toronto Use of sfrp-3 in the assessment of heart failure
CN105548563B (zh) 2009-07-27 2017-09-22 霍夫曼-拉罗奇有限公司 mimecan在评价心力衰竭中的用途
BR112012011230A2 (pt) * 2009-11-13 2016-04-05 Bg Medicine Inc fatores de risco e previsão de infarto do miocárdio
AU2011285694B2 (en) 2010-08-04 2014-12-18 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
EP2715353B1 (en) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
JP6119607B2 (ja) * 2011-09-20 2017-04-26 コニカミノルタ株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
US20140273273A1 (en) 2012-11-01 2014-09-18 Christie Mitchell Ballantyne Biomarkers to improve prediction of heart failure risk
CN103304665A (zh) * 2013-05-21 2013-09-18 上海贝西生物科技有限公司 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用
SG11201702490PA (en) 2014-10-10 2017-04-27 Akira Matsumori Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure
EP3360570A1 (en) * 2017-02-13 2018-08-15 Roche Diagnostics GmbH Antibodies recognizing genetic variants
JP7203034B2 (ja) * 2017-10-02 2023-01-12 大塚製薬株式会社 アナライトの検出方法
WO2019198822A1 (ja) * 2018-04-13 2019-10-17 共立製薬株式会社 心不全検出方法、心不全検出用器具、サンドイッチ免疫学的測定方法、並びに抗体の組合せ
CN108752480B (zh) * 2018-05-30 2022-03-29 中元汇吉生物技术股份有限公司 一种免疫原组合物、其制备方法及其用途
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
CN111487222B (zh) * 2019-01-28 2023-11-14 上海乐合生物科技有限公司 一种检测bnp的spr芯片的制备方法
JP7664226B2 (ja) 2019-08-13 2025-04-17 ゲンティアン アクティーゼルスカブ Ｎｔ－プロｂｎｐの定量のための高感度粒子増感アッセイ
JP7650966B2 (ja) * 2020-09-30 2025-03-25 エフ． ホフマン－ラ ロシュ アーゲー 心房細動の評価における、循環中の総ＮＴ－ｐｒｏＢＮＰ（グリコシル化および非グリコシル化ＮＴ－ｐｒｏＢＮＰ）ならびにそのＮＴ－ｐｒｏＢＮＰ（非グリコシル化ＮＴ－ｐｒｏＢＮＰ）との比率
CN112986586A (zh) * 2021-02-20 2021-06-18 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
CN112964885B (zh) * 2021-02-20 2022-11-11 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
ES3022063T3 (en) 2021-10-01 2025-05-28 Gentian As Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sample
WO2023175152A1 (en) 2022-03-18 2023-09-21 Roche Diagnostics Gmbh Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
CN118922721A (zh) 2022-03-18 2024-11-08 豪夫迈·罗氏有限公司 用于2型与1型急性心肌梗死的早期辨别的cMyBPC标志物组合
WO2024219421A1 (ja) * 2023-04-19 2024-10-24 栄研化学株式会社 ＮＴ－ｐｒｏＢＮＰに対する抗体、これを用いたＮＴ－ｐｒｏＢＮＰ検出方法、並びに、ＮＴ－ｐｒｏＢＮＰ検出に用いるための組成物及びキット

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
JP2665850B2 (ja) 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US6828107B2 (en) * 1997-09-11 2004-12-07 Shionogi & Co., Ltd. Immunoassay method for BNP
GB9827348D0 (en) * 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
PL204235B1 (pl) 1999-01-29 2009-12-31 Roche Diagnostics Gmbh Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych
US20030219734A1 (en) 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20040096919A1 (en) * 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
EP2256132B1 (en) * 2003-05-12 2015-04-01 Roche Diagnostics GmbH Method of detecting proBNP with a monoclonal antibody

Also Published As

Publication number Publication date
JP4430066B2 (ja) 2010-03-10
ES2548327T3 (es) 2015-10-15
EP2949669A1 (en) 2015-12-02
EP1625163B1 (en) 2011-08-31
EP2256132A1 (en) 2010-12-01
JP5128125B2 (ja) 2013-01-23
CN101967190A (zh) 2011-02-09
US7807380B2 (en) 2010-10-05
HK1097855A1 (zh) 2007-07-06
US20060110775A1 (en) 2006-05-25
CA2522378C (en) 2011-03-29
KR100857752B1 (ko) 2008-09-11
US20070099241A1 (en) 2007-05-03
JP2007535470A (ja) 2007-12-06
CA2522747A1 (en) 2004-11-18
MXPA05011826A (es) 2006-01-26
US20060110776A1 (en) 2006-05-25
ES2369008T3 (es) 2011-11-24
PL1625164T3 (pl) 2011-12-30
US7264938B2 (en) 2007-09-04
KR20060003905A (ko) 2006-01-11
CN100497393C (zh) 2009-06-10
DK1625163T3 (da) 2011-12-05
DK1625164T3 (da) 2011-10-31
ATE517124T1 (de) 2011-08-15
JP2013018784A (ja) 2013-01-31
HUE025169T2 (en) 2016-02-29
WO2004099253A1 (en) 2004-11-18
EP1625164B1 (en) 2011-07-20
DK2256132T3 (en) 2015-07-13
ATE522546T1 (de) 2011-09-15
CA2522747C (en) 2012-08-14
JP2007525427A (ja) 2007-09-06
JP5649631B2 (ja) 2015-01-07
AU2004235974A1 (en) 2004-11-18
EP1625163B8 (en) 2011-11-02
KR20080011467A (ko) 2008-02-04
EP1625163A1 (en) 2006-02-15
CN1784425A (zh) 2006-06-07
PL1625163T3 (pl) 2012-01-31
BRPI0410261B1 (pt) 2020-03-10
US20070117156A1 (en) 2007-05-24
BRPI0410261B8 (pt) 2021-07-27
ES2372282T3 (es) 2012-01-18
JP2010011860A (ja) 2010-01-21
EP2256132B1 (en) 2015-04-01
PL2256132T3 (pl) 2016-08-31
EP1625164A1 (en) 2006-02-15
WO2004099252A1 (en) 2004-11-18
CA2522378A1 (en) 2004-11-18
CN1832964A (zh) 2006-09-13
AU2004235974B2 (en) 2008-02-14
US7264939B2 (en) 2007-09-04
US7811770B2 (en) 2010-10-12
JP4834136B2 (ja) 2011-12-14

Similar Documents

Publication Publication Date Title
BRPI0410261A (pt) método de detecção de probnp natural
AR116860A2 (es) Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
EA200401198A1 (ru) АНТИТЕЛА ПРОТИВ αvβ6
BRPI0405215A (pt) Teste analìtico em sanduìche para determinar nt-probnp
BRPI0314814C1 (pt) anticorpo compreendendo uma variante de fc
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
NZ595340A (en) Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
AR066846A1 (es) Anticuerpos anti- notcchh1 nrr y sus metodos de uso
ATE428731T1 (de) Therapeutische antiköper mit reduzierten nebenwirkungen
PE20090722A1 (es) Hepcidina, antagonistas de la hepcidina y metodos de uso
WO2006086208A3 (en) 5-fluoro-uracil immunoassay
EA201100231A1 (ru) Диагностический анализ на основе антител
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
ATE395364T1 (de) Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung
CL2008002525A1 (es) Reactivo de inmunoensayo que comprende un agente de union a la troponina i y un sulfato de condroitina para reducir la union inespesifica en un ensayo para troponina i; composicion de muestra; metodo para detectar troponina i.
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
WO2008025964A3 (en) Antibodies to an epitope of agr2. assays and hybridomas
WO2006088700A3 (en) Human ring specific bnp antibodies
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
WO2019197543A3 (en) Periodontitis diagnostic methods, uses and kits
BR0314207A (pt) Imunoensaios para a determinação especìfica de isoformas de scca
NO20052870D0 (no) Immunoanalysemetode og sett for anvendelse derav
SE0100595D0 (sv) Immunological detection of prostate diseases and prostatic-related diseases

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/05/2004, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2827 DE 11-03-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.